| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.62 | 6e-05 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.52 | 0.0007 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.57 | 0.0007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.49 | 0.002 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.47 | 0.002 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |